切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (05) : 385 -390. doi: 10.3877/cma.j.issn.1672-6448.2020.05.001

所属专题: 总编推荐 文献

述评

超声心动图在肥厚型心肌病临床管理中的应用现状与思考
刘丽文1,()   
  1. 1. 710032 西安,解放军空军军医大学第一附属医院(西京医院)超声医学科 解放军空军军医大学第一附属医院(西京医院)肥厚型心肌病国际合作中心 陕西省肥厚型心肌病多学科会诊中心 西京医院肥厚型心肌病多学科诊治与遗传咨询中心
  • 收稿日期:2020-03-31 出版日期:2020-05-01
  • 通信作者: 刘丽文
  • 基金资助:
    国家国际科技合作专项(2014DFA31980); 国科金面上项目(81671693); 军队装备重点课题(KJ20191A050284); 西京医院学科助推计划(XJZT18Z03); 西京医院科技发展基金(YYKJFZJJ2018Y002); 空军军医大学科技发展基金(81671693)

Application of echocardiography in clinical management of hypertrophic cardiomyopathy

Liwen Liu1()   

  • Received:2020-03-31 Published:2020-05-01
  • Corresponding author: Liwen Liu
引用本文:

刘丽文. 超声心动图在肥厚型心肌病临床管理中的应用现状与思考[J]. 中华医学超声杂志(电子版), 2020, 17(05): 385-390.

Liwen Liu. Application of echocardiography in clinical management of hypertrophic cardiomyopathy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(05): 385-390.

1
Geske JB, Ommen SR, Gersh BJ. Hypertrophic Cardiomyopathy: Clinical Update [J]. JACC Heart Fail, 2018, 6(5): 364-375.
2
Maron BJ. Clinical course and management of hypertrophic cardiomyopathy [J]. N Engl J Med, 2018, 379(7): 655-668.
3
Christopher S, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2015, 65(12): 1249-1254.
4
Ho CY, López B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy [J]. N Engl J Med, 2010, 363(6): 552-563.
5
Maron BJ, Wolfson JK, Epstein SE, et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 1986, 8(3): 545-557.
6
Foà A, Agostini V, Rapezzi C, et al. Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy [J]. Int J Cardiol, 2019, 291: 77-82.
7
Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles [J]. JAMA, 1996, 276(3): 199-204.
8
Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2014, 35(39): 2733-2779.
9
中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组, 中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南 [J]. 中国心血管病杂志, 2017, 45(12): 1015-1032.
10
马志玲, 赵志敬, 耶闯, 等. 高血压所致左心室肥厚与肥厚型心肌病体表心电图和超声心动图的鉴别要点 [J]. 心脏杂志, 2019, 31(3): 295-301.
11
Afonso L, Kondur A, Simegn M, et al. Two-dimensional strain profles in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative analysis [J]. BMJ Open, 2012, 2: e001390.
12
Pelliccia A, Caselli S, Sharma S, et al. European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart [J]. Eur Heart J, 2018, 39(21): 1949-1969.
13
Olsen KR, LaGrew JE, Awoniyi CA, et al. Undiagnosed hypertrophic obstructive cardiomyopathy during transcatheter aortic valve replacement: a case report [J]. J Med Case Rep, 2018, 12(1): 372.
14
Vigneault DM, Yang E, Jensen PJ, et al. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking [J]. Radiology, 2019, 290(3): 640-648.
15
Santambrogio GM, Maloberti A, Vallerio P, et al. Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? [J]. Int J Cardiovasc Imaging, 2019, 35(12): 2167-2175.
16
Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy [J]. N Engl J Med, 2000, 342(24): 1778-1785.
17
Guo X, Fan C, Wang H, et al. The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular Hypertrophic Cardiomyopathy [J]. Cardiology, 2016, 133(1): 35-43.
18
Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines [J]. J Am Coll Cardiol, 2003, 42(9): 1687-1713.
19
李文霞, 王静, 杨帆, 等. 心电图和超声心动图对肥厚型心肌病钆延迟强化的预测研究 [J]. 中华超声影像学杂志, 2018, 27(8): 645-649.
20
Jain CC, Newman DB, Geske JB. Mitral Valve Disease in Hypertrophic Cardiomyopathy: Evaluation and Management [J]. Curr Cardiol Rep, 2019, 21(11): 136.
21
Groarke JD, Galazka PZ, Cirino AL, et al. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers [J]. Eur Heart J Cardiovasc Imaging, 2018, 19(10): 1109-1116.
22
Silbiger JJ. Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights [J]. J Am Soc Echocardiogr, 2016, 29(7): 622-639.
23
Patel P, Dhillon A, Popovic ZB, et al. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography [J]. Circ Cardiovasc Imaging, 2015, 8(7): e003132.
24
Kim DH, Handschumacher MD, Levine RA, et al. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction [J]. Circulation, 2010, 122(13): 1298-1307.
25
Maron BJ, Maron MS, Wigle ED, et al. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2009, 54(3): 191-200.
26
Maron MS, Olivotto I, Zenovieh AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction [J]. Circulation, 2006, 114(21): 2232-2239.
27
Morise AP. Exercise testing in nonatherosclerotic heart disease: hypertrophic cardiomyopathy, valvular heart disease, and arrhythmias [J]. Circulation, 2011, 123(6): 216-225.
28
Gao XJ, Kang LM, Zhang J, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review [J]. Chin Med J (Engl), 2011, 124(11): 1754-1757.
29
Cavalcante JL, Barboza JS, Lever HM. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2012, 54(6): 517-522.
30
Sherrid MV, Balaram S, Kim B, et al. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context [J]. J Am Coll Cardiol, 2016, 67(15): 1846-1858.
31
Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J]. N Engl J Med, 2003, 349(11): 1027-1035.
32
Seth S, Prakash R, Seth R, et al. Screening for pre-clinical hypertrophic cardiomyopathy by tissue Doppler imaging [J]. Indian Heart J, 2005, 57(3): 245-250.
33
雷常慧, 刘丽文, 纳丽莎, 等. 三维斑点追踪技术评价肥厚型心肌病患者左心室整体应变的研究 [J]. 中华超声影像学杂志, 2014, 23(5): 377-382.
34
Haland TF, Almaas VM, Hasselberg NE, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 613-621.
35
Haland TF, Hasselberg NE, Almaas VM, et al. The systolic paradox in hypertrophic cardiomyopathy [J]. Open Heart, 2017, 4: e000571.
36
Peyrou J, Reant P, Reynaud A, et al. Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography [J]. Int J Cardiovasc Imaging, 2016, 32(9): 1379-1389.
37
Serri K, Reant P, Laftte M, et al. Global and regional myocardial function quantification by two dimensional strain: application in hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2006, 47(6): 1175-1181.
38
Carasso S, Yang H, Woo A, et al. Diastolic myocardial mechanics in hypertrophic cardiomyopathy [J]. J Am Soc Echocardiogr, 2010, 23(2): 164-171.
39
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12): 1321-1360.
40
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. J Am Soc Echocardiogr, 2016, 29(4): 277-314.
41
Biagini E, Spirito P, Rocchi G, et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy [J]. Am J Cardiol, 2009, 104(2): 1727-1731.
42
van Dalen BM, Kauer F, Michels M, et al. Delayed left ventricular untwisting in hypertrophic cardiomyopathy [J]. J Am Soc Echocardiogr, 2009, 22(12): 1320-1326.
43
Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications [J]. J Am Coll Cardiol, 2006, 47(12): 2357-2363.
44
Latif SR, Nguyen VQ, Peters DC, et al. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy [J]. Int J Cardiovasc Imaging, 2019, 35(7): 1309-1318.
45
Vasquez N, Ostrander BT, Lu DY, et al. Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients [J]. J Am Soc Echocardiogr, 2019, 32(5): 593-603.
46
Nampiaparampil RG, Swistel DG, Schlame M, et al. Intraoperative Two- and Three-Dimensional Transesophageal Echocardiography in Combined Myectomy-Mitral Operations for Hypertrophic Cardiomyopathy [J]. J Am Soc Echocardiogr, 2018, 31(3): 275-288.
47
Liu L, Li J, Zuo L, et al. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy [J]. J Am Coll Cardiol, 2018, 72(16): 1898-1909.
48
Elliott PM, Gimeno JR, Thaman R, et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy [J]. Heart, 2006, 92(6): 785-791.
49
Hartlage GR, Kim JH, Strickland PT, et al. The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy [J]. Int J Cardiovasc Imaging, 2015, 31(3): 557-565.
50
D'Andrea A, Caso P, Severino S, et al. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy [J]. Echocardiography, 2005, 22(7): 571-578.
51
D'Andrea A, Caso P, Severino S, et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy [J]. Eur Heart J, 2006, 27(11): 1311-1318.
52
Zhu X, Xu L, Zuo L, et al. Quantitative Analysis of Left Ventricular Flow Dynamics in Latent Obstructive Hypertrophic Cardiomyopathy Using Vector Flow Mapping [J]. Cardiology, 2020, 145(4): 227-235.
No related articles found!
阅读次数
全文


摘要